MSB 3.83% $1.26 mesoblast limited

No biotech company in there right mind gives any real guidance...

  1. 192 Posts.
    lightbulb Created with Sketch. 137
    No biotech company in there right mind gives any real guidance until they have an approval. Thats because you cant look like your promoting and marketing your product before fda approval. When approval is obtained you can advertise the product and state its unique MOA its efficacy and lack of side effects. That may get people thinking about what else the new (drug) can be used for.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.26
Change
-0.050(3.83%)
Mkt cap ! $1.432B
Open High Low Value Volume
$1.27 $1.30 $1.17 $21.32M 17.21M

Buyers (Bids)

No. Vol. Price($)
4 5460 $1.25
 

Sellers (Offers)

Price($) Vol. No.
$1.26 978 1
View Market Depth
Last trade - 16.10pm 24/07/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.